Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Gilead Sciences Inc (GILD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 92,994,592
  • Shares Outstanding, K 1,300,260
  • Annual Sales, $ 26,107 M
  • Annual Income, $ 4,628 M
  • 36-Month Beta 1.15
  • Price/Sales 3.54
  • Price/Cash Flow 7.30
  • Price/Book 4.43

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.71 +6.54%
on 05/29/18
72.28 -1.67%
on 06/08/18
+3.24 (+4.78%)
since 05/22/18
3-Month
64.27 +10.58%
on 05/03/18
76.25 -6.79%
on 04/12/18
-4.50 (-5.95%)
since 03/22/18
52-Week
64.27 +10.58%
on 05/03/18
89.54 -20.63%
on 01/29/18
+0.59 (+0.84%)
since 06/22/17

Most Recent Stories

More News
CRISPR Science and Stocks: Knowing Enough to Invest

Can you learn enough about the science and the companies to invest with confidence?

SGMO : 16.50 (+2.33%)
CRSP : 62.78 (-3.62%)
EDIT : 39.37 (-1.03%)
GILD : 71.07 (-0.63%)
NTLA : 28.91 (-2.03%)
Gilead Sciences (GILD) Approaches New Downside Target of $68.29

Shares of Gilead Sciences (NASDAQ:GILD) opened today below their pivot of $69.31 and have already reached the first level of support at $68.67. Should the shares continue to fall, the support pivots of...

GILD : 71.07 (-0.63%)
Novartis Announces Positive Data on CAR-T Therapy, Kymriah

Novartis (NVS) announces positive results on Kymriah from the JULIET TRIAL in patients with relapsed or refractory diffuse large B-cell lymphoma.

QURE : 36.18 (-8.41%)
ONCE : 90.08 (+1.80%)
NVS : 75.06 (+1.46%)
GILD : 71.07 (-0.63%)
Gilead Sciences Set to Possibly Rebound After Yesterday's Selloff of 1.25%

Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $69.91 to a high of $71.41. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $70.51...

GILD : 71.07 (-0.63%)
After Yesterday's Decline of 1.25%, Gilead Sciences Offers Investors Better Value

Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $69.91 to a high of $71.41. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $70.51...

GILD : 71.07 (-0.63%)
Zacks Value Investor Highlights: Gilead Sciences, Biogen, Celgene, Lannett and Valeant

Zacks Value Investor Highlights: Gilead Sciences, Biogen, Celgene, Lannett and Valeant

CELG : 78.80 (-0.43%)
LCI : 14.05 (+0.36%)
GILD : 71.07 (-0.63%)
VRX : 24.27 (-1.82%)
BIIB : 296.04 (-0.44%)
NASH Space in Focus as Galmed (GLMD) Posts Positive Data

Investor focus is back on the NASH space as quite a few companies release promising data on their NASH candidates of late.

CNAT : 4.97 (-0.40%)
GALT : 7.67 (-0.52%)
MDGL : 291.25 (+2.07%)
GILD : 71.07 (-0.63%)
ICPT : 85.67 (+1.85%)
GLMD : 14.09 (-2.08%)
Consolidated Research: 2018 Summary Expectations for Encana, Netflix, Veon, The Walt Disney, Gilead Sciences, and Cloudera -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Encana Corporation (TSX:ECA),...

NFLX : 411.09 (-1.05%)
VEON : 2.30 (+0.88%)
CLDR : 14.54 (-4.22%)
ECA.TO : 16.97 (+4.62%)
GILD : 71.07 (-0.63%)
DIS : 106.34 (+0.42%)
Free Technical Reports on Gilead Sciences and Three Additional Biotech Equities

Stock Research Monitor: GERN, GBT, and GLYC

GBT : 42.05 (+1.69%)
GERN : 3.60 (+2.56%)
GILD : 71.07 (-0.63%)
Drug Stocks: The Next Hot Industry or Value Traps?

These 5 stocks look dirt cheap but is it too good to be true?

CELG : 78.80 (-0.43%)
LCI : 14.05 (+0.36%)
GILD : 71.07 (-0.63%)
VRX : 24.27 (-1.82%)
BIIB : 296.04 (-0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade GILD with:

Business Summary

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products...

See More

Key Turning Points

2nd Resistance Point 72.15
1st Resistance Point 71.61
Last Price 71.07
1st Support Level 70.68
2nd Support Level 70.29

See More

52-Week High 89.54
Fibonacci 61.8% 79.89
Fibonacci 50% 76.90
Fibonacci 38.2% 73.92
Last Price 71.07
52-Week Low 64.27

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar